The use of CBD for schizophrenia is becoming more and more common. Studies from around the world are showing great promise and my own experience with these patients and modest doses of high ratio CBD:THC dosed extracts are working very well for many.
Here are a number of references:
8. | Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. |
| Levin R, Almeida V, Peres FF, Calzavara MB, da Silva ND, Suiama MA, Niigaki ST, Zuardi AW, Hallak JE, Crippa JA, Abílio VC. |
| Curr Pharm Des. 2012;18(32):4960-5. |
| PMID: 22716146 [PubMed – in process] |
| Related citations |
16. | Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. |
| Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P, Rubia K, Kambeitz J, O’Carroll C, Seal ML, Giampietro V, Brammer M, Zuardi AW, Atakan Z, McGuire PK. |
| Arch Gen Psychiatry. 2012 Jan;69(1):27-36. doi: 10.1001/archgenpsychiatry.2011.161. |
| PMID: 22213786 [PubMed – indexed for MEDLINE] |
| Related citations |
22. | The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. |
| Hallak JE, Dursun SM, Bosi DC, de Macedo LR, Machado-de-Sousa JP, Abrão J, Crippa JA, McGuire P, Krystal JH, Baker GB, Zuardi AW. |
| Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):198-202. doi: 10.1016/j.pnpbp.2010.11.002. Epub 2010 Nov 7. |
| PMID: 21062637 [PubMed – indexed for MEDLINE] |
| Related citations |
29. | Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. |
| Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O’Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P. |
| Arch Gen Psychiatry. 2009 Apr;66(4):442-51. doi: 10.1001/archgenpsychiatry.2009.17. |
| PMID: 19349314 [PubMed – indexed for MEDLINE] |
| Related citations |
40. | Cannabinoids. |
| Grotenhermen F. |
| Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review. |
| PMID: 16266285 [PubMed – indexed for MEDLINE] |
| Related citations |
Author
Allan Frankel, MD
Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined.
Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed